Achieve Life Sciences Inc ACHV.O :
* ACHIEVE REPORTS FINANCIAL RESULTS FOR THIRD QUARTER 2018 AND PROVIDES CYTISINICLINE (CYTISINE) CLINICAL DEVELOPMENT UPDATE
* ACHIEVE LIFE SCIENCES - QTRLY LOSS PER SHARE $0.71
Achieve Life Sciences Inc ACHV.O :
* ACHIEVE REPORTS FINANCIAL RESULTS FOR THIRD QUARTER 2018 AND PROVIDES CYTISINICLINE (CYTISINE) CLINICAL DEVELOPMENT UPDATE
* ACHIEVE LIFE SCIENCES - QTRLY LOSS PER SHARE $0.71